Nectar RHS Komplementar ApS: Financial statements 2024
CVR: 41934530
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Nectar RHS Komplementar ApS (CVR 41934530) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -5,000 and a net result of DKK 58,075 compared with DKK 15,307 the year before. Equity in the 2024 report amounted to DKK 138,567. The solvency ratio was 86.4%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -5,000
- Profit/Loss
- DKK 58,075
- Equity
- DKK 138,567
- Total Assets
- DKK 160,316
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -5 t. | 58 t. | 139 t. | 1 |
| 2023 | - | -5 t. | 15 t. | 80 t. | 1 |
| 2022 | - | -13 t. | 10 t. | 65 t. | 0 |
| 2021 | - | -5 t. | 16 t. | 56 t. | 0 |
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Nectar RHS Komplementar ApS has published its annual report for 2023. Gross profit came to DKK -5,000, and the net result was DKK 15,307.
About Nectar RHS Komplementar ApS
Nectar RHS Komplementar ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2020. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Bjørk Krogshave. The company is owned by PharmaService I/S and Nectar Invest A/S. In 2025, the company reported a gross profit of DKK -5,000 and a net result of DKK 38,849 compared with DKK 58,075 the year before. Equity in the 2025 report amounted to DKK 177,416.